These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12399880)

  • 41. Intracranial hypertension in systemic lupus erythematosus.
    Dave S; Longmuir R; Shah VA; Wall M; Lee AG
    Semin Ophthalmol; 2008; 23(2):127-33. PubMed ID: 18320479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Borderline systemic lupus erythematosus (SLE): a separate entity or a forerunner to SLE?
    Al Attia HM
    Int J Dermatol; 2006 Apr; 45(4):366-9. PubMed ID: 16650159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protein-losing enteropathy in systemic lupus erythematosus: analysis of the clinical features of fifteen patients.
    Zheng WJ; Tian XP; Li L; Jing HL; Li F; Zeng XF; Tang FL
    J Clin Rheumatol; 2007 Dec; 13(6):313-6. PubMed ID: 18176138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autoimmune hepatitis in a patient with systemic lupus erythematosus.
    Iwai M; Harada Y; Ishii M; Tanaka S; Muramatsu A; Mori T; Nakashima T; Okanoue T; Hirohata S
    Clin Rheumatol; 2003 Sep; 22(3):234-6. PubMed ID: 14505218
    [TBL] [Abstract][Full Text] [Related]  

  • 45. EULAR points to consider for conducting clinical trials in systemic lupus erythematosus.
    Gordon C; Bertsias G; Ioannidis JP; Boletis J; Bombardieri S; Cervera R; Dostál C; Font J; Gilboe IM; Houssiau F; Huizinga TW; Isenberg D; Kallenberg CG; Khamashta MA; Piette JC; Schneider M; Smolen JS; Sturfelt G; Tincani A; Van Vollenhoven R; Boumpas DT
    Ann Rheum Dis; 2009 Apr; 68(4):470-6. PubMed ID: 18388158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chylothorax as the initial presentation of systemic lupus erythematosus: a case report.
    Lin YJ; Chen DY; Lan JL; Hsieh TY
    Clin Rheumatol; 2007 Aug; 26(8):1373-4. PubMed ID: 16927041
    [No Abstract]   [Full Text] [Related]  

  • 47. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.
    Cambridge G; Isenberg DA; Edwards JC; Leandro MJ; Migone TS; Teodorescu M; Stohl W
    Ann Rheum Dis; 2008 Jul; 67(7):1011-6. PubMed ID: 17962238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment.
    Smith KG; Jones RB; Burns SM; Jayne DR
    Arthritis Rheum; 2006 Sep; 54(9):2970-82. PubMed ID: 16947528
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coronary artery bypass grafting in patients with systemic lupus erythematosus.
    Bossert T; Falk V; Gummert JF; Rahmel A; Mohr FW
    Z Kardiol; 2003 Mar; 92(3):219-21. PubMed ID: 12658468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project".
    Cervera R; Abarca-Costalago M; Abramovicz D; Allegri F; Annunziata P; Aydintug AO; Bacarelli MR; Bellisai F; Bernardino I; Biernat-Kaluza E; Blockmans D; Boki K; Bracci L; Campanella V; Camps MT; Carcassi C; Cattaneo R; Cauli A; Cervera R; Chwalinska-Sadowska H; Contu L; Cosyns JP; Danieli MG; DCruz D; Depresseux G; Direskeneli H; Domènech I; Espinosa G; Fernández-Nebro A; Ferrara GB; Font J; Frutos MA; Galeazzi M; Garcìa-Carrasco M; García Iglesias MF; García-Tobaruela A; George J; Gil A; González-Santos P; Grana M; Gül A; Haga HJ; de Haro-Liger M; Houssiau F; Hughes GR; Ingelmo M; Jedryka-Góral A; Khamashta MA; Lavilla P; Levi Y; López-Dulpa M; López-Soto A; Maldykowa H; Marcolongo R; Mathieu A; Morozzi G; Nicolopoulou N; Papasteriades C; Passiu G; Perelló I; Petera P; Petrovic R; Piette JC; Pintado V; de Pita O; Popovic R; Pucci G; Puddu P; de Ramón E; Ramos-Casals M; Rodríguez-Andreu J; Ruiz-Irastorza G; Sanchez-Lora J; Sanna G; Scorza R; Sebastiani GD; Sherer Y; Shoenfeld Y; Simpatico A; Sinico RA; Smolen J; Tincani A; Tokgöz G; Urbano-Márquez A; Vasconcelos C; Vázquez JJ; Veronesi J; Vianna J; Vivancos J;
    Autoimmun Rev; 2006 Mar; 5(3):180-6. PubMed ID: 16483917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dyspnoea in a young woman with active systemic lupus erythematosus.
    Todd DJ; Costenbader KH
    Lupus; 2009 Aug; 18(9):777-84. PubMed ID: 19578101
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura.
    Hazzan R; Mukamel M; Yacobovich J; Yaniv I; Tamary H
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):657-9. PubMed ID: 16933242
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Socioeconomic factors in lupus erythematosus.
    Meller S; Homey B; Ruzicka T
    Autoimmun Rev; 2005 Apr; 4(4):242-6. PubMed ID: 15893719
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evolution of lesions over 10 years in a patient with SLE: flowchart approach to the new International Society of Nephrology (ISN)/Renal Pathology Society (RPS) classification of lupus nephritis.
    Elliot V; Cairns T; Cook HT
    Am J Kidney Dis; 2006 Jan; 47(1):184-90. PubMed ID: 16377401
    [No Abstract]   [Full Text] [Related]  

  • 55. [Systemic lupus erythematosus].
    Miescher PA
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1807-13. PubMed ID: 148179
    [No Abstract]   [Full Text] [Related]  

  • 56. Chloroquine Toxicity Misdiagnosed as Fabry Disease Associated with Systemic Lupus Erythematosus and Hashimoto Thyroiditis.
    Navratil M; Ivković Jureković I
    J Rheumatol; 2017 Dec; 44(12):1940. PubMed ID: 29196549
    [No Abstract]   [Full Text] [Related]  

  • 57. [Follow-up in systemic lupus erythematosus].
    Krause A; Goebel KM
    Dtsch Med Wochenschr; 1989 Sep; 114(36):1383. PubMed ID: 2776663
    [No Abstract]   [Full Text] [Related]  

  • 58. Off by a factor of eight.
    Eldred EB
    J Miss State Med Assoc; 2010 Aug; 51(8):211-3. PubMed ID: 21365978
    [No Abstract]   [Full Text] [Related]  

  • 59. [New findings regarding the clinical outcome of rheumatic diseases].
    Gromnica-Ihle E; Ganser G; Genth E
    Internist (Berl); 2001 Feb; 42(2):237-8, 241-9. PubMed ID: 11244878
    [No Abstract]   [Full Text] [Related]  

  • 60. [Sequelae of improved prognosis of SLE].
    Manger K; Manger B
    Z Rheumatol; 2002 Oct; 61(5):532-3. PubMed ID: 12399880
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.